The Use of Timolol in Reducing the Incidence of Supraventricular Arrhythmias After Coronary Artery Bypass Surgery
| Autor: | C. Liassides, R. J. Vecht, J. Cleary, E. P. Nicolaides, J. Ikwueke |
|---|---|
| Rok vydání: | 1984 |
| Předmět: |
medicine.medical_specialty
Supraventricular arrhythmia business.industry medicine.medical_treatment Hemodynamics Postoperative complication Timolol Cardioversion Coronary artery bypass surgery medicine.anatomical_structure Blood pressure Internal medicine Anesthesia Cardiology Medicine business Artery medicine.drug |
| Zdroj: | Coronary Artery Surgery ISBN: 9783540132646 |
| DOI: | 10.1007/978-3-642-69638-1_15 |
| Popis: | A review of 13 publications dealing with the development of supraventricular arrhythmias after coronary artery bypass graft yielded a mean overall incidence of 27.5% (Table 1) [1–12]. In the U.S.A. some 100000 such operations are performed yearly [13] and something on the order of 30000 patients develop this postoperative complication. These arrhythmias often require cardioversion and invariably drug therapy. They can cause a drop in arterial pressure which could have deleterious effects on graft haemodynamics and subsequent long-term patency. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|